ÐÓ°ÉÊÓÆµ

Skip to main content
lab-research

Medicine's Drew Adams and Paul Tesar publicly launch Convelo Therapeutics

MEDIA | August 6, 2018
STORY BY: EDITORIAL STAFF
Crain's Cleveland Business: Research discoveries made by Drew Adams, the Thomas F. Peterson, Jr. Professor of Novel Therapeutics, and Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, led to the founding of Convelo Therapeutics, a company seeking to discover and develop new medications for some neurological conditions.
EXPLORE MORE:
MEDIA